Cancer Weekly articles from February 1991

Cancer Weekly archives from February 1991

New drug combination potentially effective against bladder cancer. (cisplatin and 5-fluorouracil) (Duke University Medical Center)
February 4, 1991... Duke University Medical Center Clinical trials involving humans will begin soon at Duke University Medical Center, Durham, North Carolina, to test a new combination of chemotherapeutic agents for advanced bladder cancer, researchers...

Childhood cancer may be caused by smoking's effect on sperm. (National Institute of Environmental Health Sciences)
February 4, 1991... A new study in the American Journal of Epidemiology says that smoking may damage a father's sperm and result in children with increased risk of brain cancer and leukemia. Dale P. Sandler of the U.S. National Institute of Environmental...

Children of smoking parents more likely to have infectious diseases. (Yale University School of Medicine)
February 4, 1991... Children whose parents smoke are three to four times more likely to develop serious infectious diseases requiring hospitalization, according to a new study. "I don't think anyone before has demonstrated that the association is not just...

Permanent occupational disability caused by secondhand smoke. (Wisconsin)
February 4, 1991... A state commission has awarded a Wisconsin Bell employee disability benefits because of secondhand smoke exposure over an eight-year period. The decision was handed down by the Labor and Industry Review Commission of Wisconsin. It was...

Oxygen free radicals implicated in cancer and immune system damage. (Duke University)
February 4, 1991... Two enzymes crucial to cell growth are destroyed by oxygen free radicals, a by-product of respiration, a Duke University Medical Center biochemist has reported. The cumulative effects of these free radicals are being implicated in...

Rise in breast cancer risks in 1991. (American Cancer Society)
February 4, 1991... According to the American Cancer Society's (ACS) 1991 "Cancer Facts and Figures," the average American woman's lifetime risk for developing breast cancer has risen from one in 10 women to one in nine. In 1991, it is estimated that...

State considers mandatory mammogram coverage bill. (Indiana)
February 4, 1991... Businesses providing health insurance to employees may have to include coverage for breast cancer screening under a bill in the Indiana House of Representatives. Insurance industry lobbyists reportedly are opposed to the bill. The...

Conference to focus on interventional procedures for breast cancer diagnosis. (Siemens Medical Systems Inc.)
February 4, 1991... Siemens Medical Systems, Inc., Iselin, New Jersey, is sponsoring a three-day workshop conference on interventional procedures for breast cancer diagnosis from June 17-19 in Hilton Head, South Carolina. The conference is being presented by...

Dioxin may cause cancer, but potency may be slight. (Canada)
February 4, 1991... Although dioxin may cause cancer, its danger may be less than previously thought, according to new reports in the New England Journal of Medicine (NEJM) (see also Periodical Report, this issue, pp. 19-20). "It is conceivable, although by...

Gene therapeutics direct approach may be the answer for fighting muscular dystrophy, cystic fibrosis, Parkinson's disease without cancer side effect. (Vical Inc.)
February 4, 1991... Classical gene therapy's one-time treatment approach to curing diseases may need to share the limelight with a new tactic, called gene therapeutics. This new model for the therapeutic use of DNA and messenger RNA to treat genetic...

New Taxol orders from Bristol-Myers Squibb total over $9.5 million. (antitumor compound) (Hauser Chemical Research Inc.)
February 4, 1991... Hauser Chemical Research Inc. announced that it received new supply orders from Bristol-Myers Squibb for continuing supply of Taxol, a promising antitumor compound, and related raw materials. The supply orders are valued at over...

Taxol production collides with protection of spotted owl. (antitumor compound derived from Pacific yew tree bark) (U.S. National Cancer Institute)
February 4, 1991... The U.S. National Cancer Institute (NCI) has a goal of 720,000 pounds of Pacific yew bark needed to produce 55 pounds of taxol, an antitumor compound in phase III cancer trials in humans. Officials from the NCI, the U.S. Forest Services,...

Human testing completed for remotely programmable infusion system. (home health care drug infusion) (I-Flow Corp.)
February 4, 1991... I-Flow Corp., manufacturer of a drug infusion system for the home health care market, announced that it has completed human testing and will begin marketing its remotely programmable infusion system. The VIVUS 4000 is the first ambulatory...

Rights acquired to new system that tests for cancer and HIV. (subsidiary Syva Co.) (Syntex Corp.)
February 4, 1991... Syntex Corp., Palo Alto, California, said that Syva Company, a medical diagnostics subsidiary of Syntex, has acquired exclusive worldwide rights to an automated instrument system that performs diagnostic testing for cancer, HIV, anemia,...

Applied bioTechnology, Inc. buys half of Oncogenetic Partners. (Du Pont Co.)
February 4, 1991... Applied bioTechnology, Inc. (AbT), Cambridge, Massachusetts, has purchased the du Pont Company's half share in Oncogenetic Partners. Formed in 1986 by du Pont and AbT, Oncogenetic Partners develops products that detect, treat and prevent...

Researchers report greater reduction in ozone layer. (Sweden)
February 4, 1991... The area of depleted ozone around the earth is more widespread than had been expected for this winter. "We have an indication, not a proof, that these 'mini-holes' are indeed the first sign of a depletion of the ozone layer caused by...

Glaxo Canada Inc. and IAF BioChem International Inc. sign C$25 million strategic alliance agreement. (to commercialize future therapeutic compounds) (Canada)
February 4, 1991... Pursuant to an agreement in principle reached in November 1990, Glaxo Canada Inc. (Glaxo), a wholly owned subsidiary of British based Glaxo Holdings plc, and IAF BioChem International Inc. (IAF BioChem), signed an agreement to form a 50-50...

Consolidation of corporate research activities announced. (The Liposome Company)
February 4, 1991... The Liposome Company, Inc. announced its decision to consolidate all of its research activities into a single organization at its corporate headquarters in Princeton, N.J. The company will continue to engage in discovery research, while...

Record $4.3 billion shortfall in Medicaid payments threatens access to hospital services. (American Hospital Association)
February 4, 1991... The government underpaid hospitals a record $4.3 billion in 1989 for Medicaid, widening the gap between the number of public dollars earmarked for the program and the actual cost of treating the nation's neediest, according to a study released...

Cancer death rates highest in U.S. (Maryland)
February 4, 1991... Alcohol and tobacco use may be the reasons Maryland leads the U.S. in cancer death rates, according to state health officials. Dr. John Southard of the Maryland Department of Health and Mental Hygiene said that 42 percent of the state's...

New clinical affairs director appointed. (John S. Holcenberg) (Immunex Research and Development Corp.)
February 4, 1991... Immunex Research and Development Corp., Seattle, Washington, a subsidiary of Immunex Corp., announced the appointment of John S. Holcenberg, M.D., as vice president and director, clinical affairs. Dr. Holcenberg joins Immunex from...

Dan Kohl becomes president of HMSS Inc. (Houston)
February 4, 1991... Daniel J. Kohl, 34, has been named president and chief operating officer of HMSS Inc., Houston, Texas. He began his new responsibilities on January 21, 1991. HMSS provides home infusion therapy for patients who require intravenous care...

Interleukin-6: receptor, nuclear factor, and signal transducer. (Research Report)
February 4, 1991... AUTHORS: Tadamitsu Kishimoto, Tetsuya Taga, Masahiko Hibi, Masaaki Murakami, Hiroshi Ishiki and Shizuo Akira. Osaka University, Osaka, Japan. According to the authors' abstract of a presentation to the M.D. Anderson Cancer Center's...

Suppression of new oncogene-induced transformation by the adenovirus-5 E1A gene products. (Research Report)
February 4, 1991... AUTHORS: Dihua Yu and Mien-Chie Hung. M.D. Anderson Cancer Center, Houston, Tex. According to the authors' abstract of a presentation to the M.D. Anderson Cancer Center's 43rd Annual Symposium on Fundamental Cancer Research, held in...

Role of epidermal growth factor receptors in growth responses of breast and endometrial cancer cells in vitro. (Research Report)
February 4, 1991... AUTHORS: A. Jamil and J.O. White. Royal Postgraduate Medical School, London. According to the authors' abstract of a presentation to the M.D. Anderson Cancer Center's 43rd Annual Symposium on Fundamental Cancer Research, held in...

Co-culture models in breast cancer cell lines. (Research Report)
February 4, 1991... AUTHORS: G. Di Fronzo, V. Cappelletti, D. Coradini, E. Scanziani and C. Ruedl. National Tumor Institute, Milan, Italy. According to the authors' abstract of a presentation to the M.D. Anderson Cancer Center's 43rd Annual Symposium on...

Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested? (Periodical Report)
February 4, 1991... SOURCE: Cancer, February 1, 1991; 67(3):547-9. The results of a Finnish study of interferon in the treatment of metastatic carcinoid tumors agree with several others suggesting that the therapy is not as useful as has been reported. ...

CA 50 determination in body fluids: can we screen patients at risk for gastric cancer? (antigen) (Periodical Report)
February 4, 1991... SOURCE: International Journal of Cancer, January 15, 1991; 47:7-11. The presence of CA 50 in gastric juices appears to be an indicator of certain cancers, but the marker does not appear to be specific for gastric cancer, according to an...

Migration stimulating activity in serum of breast cancer patients. (cell migration as screening tool) (Periodical Report)
February 4, 1991... SOURCE: The Lancet, January 19, 1991; 337(8734):130-133. Migration stimulating activity appears to be a potential cancer screening tool for people at high risk for malignant disease, according to a University of Manchester study. ...

Cancer mortality in workers exposed to 2,3,7,8,-tetrachlorodibenzo-p-dioxin. (Periodical Report)
February 4, 1991... SOURCE: The New England Journal of Medicine, January 24, 1991; 213(4):212-219. A study of mortality among 5172 workers with occupational exposure to dioxin does not confirm the high relative cancer risks reported in previous studies,...

Primary treatment of large and massive adult sarcomas with iododeoxyuridine and aggressive hyperfractionated irradiation. (Periodical Report)
February 4, 1991... SOURCE: Cancer, February 1, 1991; 67(3):572-577. Hyperfractionated radiation combined with intravenous administration of the radiosensitizer iododeoxyuridine is an acceptable first-line treatment for unresectable adult sarcomas,...

Cancer linked to radiation dosage. (study of nuclear workers) (Oak Ridge National Laboratory)
February 11, 1991... Oak Ridge National Laboratory - by Salynn Boyles, Research Editor For the first time in the United States researchers have linked radiation dosage to the risk of cancer death in a study of nuclear workers at Tennessee's Oak Ridge...

First cancer patients in human gene therapy trial treated. (U.S. National Institutes of Health)
February 11, 1991... U.S. NIH Scientists at the U.S. National Institutes of Health (NIH) have treated the first cancer patients in a human gene therapy trial. Two patients received transfusions of special cancer-killing cells removed from their own...

First non-government gene transfer approved by U.S. NIH. (National Institutes of Health, followed by articles on Pittsburgh Cancer Institute's research proposal and on a gene therapy patient's progress.) (Tennessee)
February 11, 1991... Tennessee A committee of the U.S. National Institutes of Health (NIH) has approved a plan by Tennessee researchers involving the first non-government human gene transfer. The St. Jude Children's Research Hospital, Memphis,...

New studies needed on relationship of oral contraceptives to breast cancer. (Institute of Medicine)
February 11, 1991... Institute of Medicine Since the pill was introduced in 1960, at least 50 million women in the U.S. have used it as a method of birth control, and 80 percent of 35-year-old women currently are using or have used it. There have been...

Hypoxic cells studied. (Stanford University)
February 11, 1991... Stanford University Two Stanford University researchers suggest that hypoxic cells, long considered an obstacle to the treatment of solid tumors, may actually offer a therapeutic advantage in future cancer treatment. Hypoxia, or low...

Zofran launched for cancer chemotherapy-induced emesis. (drug) (Glaxo)
February 11, 1991... Glaxo Glaxo Inc. announced the introduction of Zofran (ondansetron HCI) injection for the prevention of nausea and vomiting (emesis) in cancer patients receiving chemotherapy. Zofran is the first of a new class of agents known as...

Bristol-Myers Squibb announces Taxol agreement. (research on antitumor compound) (U.S. National Cancer Institute)
February 11, 1991... U.S. NCI Bristol-Myers Squibb Company announced that it has signed a Collaborative Research and Development Agreement (CRADA) with the U.S. National Cancer Institute (NCI) for clinical development of Taxol, a novel compound that has...

Response to passage of Agent Orange Bill of 1991 praised. (American Legion)
February 11, 1991... American Legion The passage of the Agent Orange Bill of 1991 is a small step for Vietnam veterans that was a long time coming, a spokesman for The American Legion said. The White House has said President Bush will sign the...

Attacks on breast implants assailed. (Philadelphia Society of Plastic Surgeons)
February 11, 1991... Philadelphia Society of Plastic Surgeons According to Charles Pappas, M.D., president of The Philadelphia Society of Plastic Surgeons (PSPS), the recent "media assault" on the use of breast implants has unnecessarily alarmed patients and...

Psychiatric problems less important than physical ones to cancer patients. (University of Iowa)
February 11, 1991... University of Iowa Cancer's toll on the body, rather than emotional issues, is of greatest distress to people with the disease, finds a study by University of Iowa College of Medicine psychiatry researchers. A 22-item Illness...

Teenagers will smoke if friends do. (University of Iowa)
February 11, 1991... University of Iowa If your teenager's friends smoke, chances are that he or she will become a smoker, finds a University of Iowa (UI) College of Medicine study. Adolescents who became regular smokers by 11th grade tended to have...

Cancer patients learn how to look good, feel better. (University of California, San Francisco)
February 11, 1991... University of California, San Francisco Part of the cancer unit at University of California, San Francisco (UCSF), looked like a beauty salon on February 4, when cancer patients, who are undergoing chemotherapy or radiation treatments,...

Quality of radon detectors varies. (University of Iowa)
February 11, 1991... University of Iowa The quality of commercially available radon detectors varies considerably and more controls are needed to assure accuracy, finds a University of Iowa (UI) College of Medicine study. Four of the six radon detectors...

Ecology Department seeks public comment on proposed air toxics rule. (State of Washington)
February 11, 1991... State of Washington Air pollution from more than 500 toxic or cancer-causing chemicals would become subject to new controls under a statewide rule proposed by the Washington State Department of Ecology (WSDE), the agency said. The...

CTHI announces agreement for new center. (Cancer Treatment Holdings Inc. in agreement with Palm Beach Cancer Care Inc. for center in West Palm Beach) (Florida)
February 11, 1991... Florida Cancer Treatment Holdings Inc. (CTHI), Fort Lauderdale, Florida, announced that CTI of Palm Beach Inc., a wholly-owned subsidiary of CTHI, has entered into an agreement with Palm Beach Cancer Care Inc. (PBCC), to establish a...

Environmental groups challenge Maryland dioxin standard. (Environmental Defense Fund and others file suit) (Maryland)
February 11, 1991... Maryland The Environmental Defense Fund, Richmond, Virginia, released the following: "Five national and regional environmental groups and several individuals filed a lawsuit in federal court challenging the U.S. Environmental...

Clinical and commercial development alliance in Central and Latin America. (with Tecnofarma S.A.) (Cell Technology)
February 11, 1991... Cell Technology Cell Technology, Inc., Boulder, Colorado, a manufacturer and distributor of pharmaceutical products, announced the consummation of a comprehensive clinical and commercial development alliance with Tecnofarma, S.A.,...

Grants selected for $3.8 million in Comptech funds. (Department of Commerce, Office of Competitive Technology) (California)
February 11, 1991... California The California Department of Commerce, Office of Competitive Technology, has selected 18 projects to receive $3.8 million in state grants to promote commercialization of research carried out in non-profit research institutions...

Dr. Robert C. Jackson named vice president of R&D. (research and development) (Agouron Pharmaceuticals)
February 11, 1991... Agouron Pharmaceuticals Agouron Pharmaceuticals Inc. announced the appointment of Robert C. Jackson, Ph.D., to the position of vice president, research and development. Immediately prior to joining Agouron, Dr. Jackson headed the...

Diagnostic businesses sold, including Isostat. (microbial system) (Du Pont Medical Products)
February 11, 1991... Du Pont Du Pont Medical Products has sold three nonstrategic diagnostic businesses to focus resources on its core business in the 'aca' and 'Dimension' clinical chemistry instruments and tests. "These sales complete a key element...

Acquisitions made in Arizona and New Hampshire. (Applied Orthotics and Prosthetics Technologies, Dave's Custom Orthotics) (Orthopedic Services)
February 11, 1991... Orthopedic Services Orthopedics Services, Inc. (OSI), Wayne, Pennsylvania, a provider of patient care services to the orthotic and prosthetic industry, announced that it has acquired Applied Orthotics and Prosthetics Technologies (AOPT)...

Western regional office collected record $241,168 from asbestos violators. (U.S. Environmental Protection Agency)
February 11, 1991... U.S. EPA The U.S. Environmental Protection Agency (EPA) western regional office collected a record $241,168 in civil penalties from violators of federal asbestos removal regulations in 1990. The figure represents the highest annual...

N-CAM as prognostic marker for human lung cancer. (neural cell adhesion molecule) (Research Report)
February 11, 1991... AUTHORS: Rob Michalides, Kitty Moolenaar, Gert Brunekreef, Robby Kibbelaar and Wolter Mooi. The Netherlands Cancer Institute, Amsterdam, The Netherlands. According to the authors' abstract of a presentation to the M.D. Anderson Cancer...

Retinoic acid pretreatment enhances tumorigenicity. (Research Report)
February 11, 1991... AUTHORS: Tapas Mukhopadhyay, Adriana C. Cavender, Kang Fang and Jack A. Roth. M.D. Anderson Cancer Center, Houston, Tex. According to the authors' abstract of a presentation to the M.D. Anderson Cancer Center's 43rd Annual Symposium On...

Molecular dissection of early events in G1 progression. (Research Report)
February 11, 1991... AUTHORS: Carol Beadling, Kirk W. Johnson and Kendall A. Smith. Dartmouth Medical School, Hanover, New Hampshire. According to the authors' abstract of a presentation to the M.D. Anderson Cancer Center's 43rd Annual Symposium On...

Characterization of human osteosarcoma-derived cell lines and the effects of epidermal growth factor and transforming growth factor beta1 and on cell proliferation. (Research Report)
February 11, 1991... AUTHORS: Katherine Estes, Gary Michels, Beth A. Lloyd and Michael H. McGuire. Creighton University, Omaha, Nebraska. According to the authors' abstract of a presentation to the M.D. Anderson Cancer Center's 43rd Annual Symposium On...

Molecular and cellular response of a human squamous cell carcinoma cell line 2,3,7,8-tetrachlorodibenzo-p-dioxin. (Research Report)
February 11, 1991... AUTHORS: K.W. Gaido, S.C. Maness and W.F. Greenlee. Research Triangle Park, N.C. According to the authors' abstract of a presentation to the M.D. Anderson Cancer Center's 43rd Annual Symposium On Fundamental Cancer Research, held in...

Endocytosis as an obligate step in intracellular signaling by interleukin-2. (Research Report)
February 11, 1991... AUTHORS: Stephen J. LeGrue and Yuti Chernajovsky. M.D. Anderson Cancer Center, Houston, Tex. According to the authors' abstract of a presentation to the M.D. Anderson Cancer Center's 43rd Annual Symposium On Fundamental Cancer...

Kaposi's sarcoma and non-Hodgkin's lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries. (Periodical Report)
February 11, 1991... SOURCE: International Journal of Cancer, January 15, 1991;49-53. There appears to be no geographically-specific increase in the incidence of Kaposi's sarcoma (KS) in Mediterranean countries since the beginning of the AIDS epidemic,...

Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. (Periodical Report)
February 11, 1991... SOURCE: Journal of the National Cancer Institute, February 6, 1991;83(3):170-177. The so-called stress response protein (srp-27) appears to be associated with more aggressive breast cancers and may have a prognostic role in the...

Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. (Periodical Report)
February 11, 1991... SOURCE: New England Journal of Medicine, January 24, 1991;324(4):219-226. Immunocytologic analysis of bone marrow appears to be a more sensitive prognostic tool in neuroblastoma than conventional morphologic bone marrow analysis,...

Brief intensive chemotherapy for metastatic non-small-cell lung cancer: a phase II study of the weekly code regimen. (Periodical Report)
February 11, 1991... SOURCE: Journal of the National Cancer Institute, February 6, 1991;83(3):190194. A short course of intensive chemotherapy may be more beneficial in the treatment of metastatic non-small-cell lung cancer than a longer regimen, according...

The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy. (Periodical Report)
February 11, 1991... SOURCE: Cancer, February 1, 1991;67(3):716-721. A Wayne State University study found that infection contributed to 44 percent of the deaths among a group of patients with head and neck cancer. Infection is a major cause of...

Coffee consumption and bladder cancer risk. (Periodical Report)
February 11, 1991... SOURCE: Cancer Research, February 1, 1991;47:207-212. A French study suggests a significant relationship between coffee consumption and bladder cancer risk for men, but no such relationship was found for women. Numerous studies...

Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice. (4-amino-1-hydroxybuthylidene-1,1-bisphosphonate, malignant bone tumor) (Periodical Report)
February 11, 1991... SOURCE: Cancer, February 1, 1991;67(3):643-648. The new bisphosphonate 4-amino-1-hydroxybuthylidene-1,1-bisphosphonate (AHBuBP) may have clinical application in the treatment of malignant bone disease, according to a Japanese study. ...

Smoking-attributable mortality and years of potential life lost - United States, 1988. (Periodical Report)
February 11, 1991... SOURCE: Morbidity and Mortality Weekly Report, January 31, 1991. "Smoking is a leading cause of diseases associated with premature mortality in the United States; in 1985, these diseases accounted for an estimated 390,000 premature...

Epidemiology in Action course. (cosponsored by Centers for Disease Control and Emory University) (Periodical Report)
February 11, 1991... SOURCE: Morbidity and Mortality Weekly Report, January 31, 1991. "U.S. CDC and Emory University will cosponsor a course designed for practicing state and local health department professionals. This course, "Epidemiology in Action," will...

University of Southern California study suggests leukemia hazard from electromagnetic fields. (Electric Power Research Institute)
February 18, 1991... Electric Power Research Institute A study sponsored by the Electric Power Research Institute, Palo Alto, California, found children who live near power lines and use certain electrical appliances are twice as likely to develop leukemia....

Designer mice simplify test of MDR reversing agents. (multidrug resistance) (U.S. National Cancer Institute)
February 18, 1991... U.S. NCI A report by a group of U.S. National Cancer Institute (NCI) researchers suggests that a new line of genetically engineered mice may aid in the study of chemoresistance. Multidrug resistance (MDR) gene is expressed in many...

Final testing begins in FDA-approved study for hepatitis-B drug Thymosin alpha 1. (Alpha 1 Biomedicals, Inc.)
February 18, 1991... Alpha 1 Biomedicals, Inc. Alpha 1 Biomedicals, Inc. announced that final testing has begun in an FDA-approved Phase III human clinical trial of Thymosin alpha 1, a new drug for the treatment of chronic hepatitis B. The first...

Household radon risk may need revision, expert panel concludes. (lung cancer risk) (National Research Council)
February 18, 1991... National Research Council Radon risk estimates based on models derived from the exposure of underground miners may overestimate the actual risk of developing lung cancer from household exposure by as much as 30 percent, according to a...

Tests detecting human papillomavirus in Pap smear samples launched. (Enzo Biochem)
February 18, 1991... Enzo Biochem Enzo Biochem Inc., New York, New York, announced that its wholly-owned diagnostic product subsidiary, Enzo Diagnostics Inc., has launched two new tests for the detection of human papillomavirus (HPV) infections in cervical...

Rare familial cancer linked to p53 gene. (Li-Fraumeni syndrome) (Massachusetts General Hospital)
February 18, 1991... Massachusetts General Hospital The identification of the cause of the rare familial cancer known as Li-Fraumeni syndrome could have far reaching significance in the future treatment of this and other family-linked cancers. In...

AIDS-related cancers under-reported. (Kaposi's sarcoma) (San Francisco)
February 18, 1991... San Francisco According to the San Francisco (California) Department of Public Health AIDS Office, a recent linkage of datasets from the San Francisco AIDS Registry and the California Tumor Registry revealed that each registry missed 20...

Avoiding smoking best way to prevent bladder cancer. (Stanford University)
February 18, 1991... Stanford University Seeking medical help after noticing blood in the urine or discomfort when voiding may be one of the best ways to survive bladder cancer, but perhaps the best way to prevent this in the first place is to avoid smoking,...

Colorectal cancer survival rates higher for patients from outside New York City. (American Society of Colon and Rectal Surgeons)
February 18, 1991... American Society of Colon and Rectal Surgeons Survival rates are higher for colorectal patients who came to a New York City hospital from outside the local community than for those from the immediate area, according to a study reported in...

Contract to measure levels of ozone exposure in humans. (awarded by Health Effects Institute) (Louisiana State University)
February 18, 1991... Louisiana State University Louisiana State University (LSU), Baton Rouge, Louisiana, researchers have been awarded a contract totaling a half-million dollars to develop methods to measure levels of ozone exposure in humans. ...

Ganite available for cancer-related hypercalcemia. (drug) (Fujisawa Pharmaceutical Company)
February 18, 1991... Fujisawa Pharmaceutical Company A new drug developed by Fujisawa USA, Inc., and a team of researchers at New York's Memorial Sloan-Kettering Cancer Center to treat cancer-related hypercalcemia - a life-threatening complication caused by...

New UVA software licensed for improved detection of breast cancer. (University of Virginia) (Dynatech Computer Systems Inc.)
February 18, 1991... Dynatech A new software system that diagnoses and evaluates breast cancer and a form of hardening of the arteries has been licensed to Dynatech Computer Systems Inc., Mountain View, Calif., by Virginia's Center for Innovative Technology...

New Orphan Drug Act regulations proposed. (U.S. Food and Drug Administration)
February 18, 1991... U.S. FDA The U.S. Food and Drug Administration (FDA) has proposed that a drug can be designated as an "orphan" if it is intended to treat a rare disease or condition that affects fewer than 200,000 patients in the U.S. The new...

Health and Hospitals president says businesses must focus on primary health care. (J. Emilio Carrillo, New York City Health and Hospitals Corp.) (New York City)
February 18, 1991... New York City J. Emilio Carrillo, president of the New York City Health and Hospitals Corporation (HHC), told the Queens Chamber of Commerce that community based primary care is the key to reducing the costs of health care and health...

Hospitals' ability to meet demand in question. (deterioration of metropolitan safety net hospitals) (National Association of Public Hospitals)
February 18, 1991... National Association of Public Hospitals The nation's metropolitan area safety net hospitals have deteriorated during the last decade, and unless new nationwide programs are enacted to fund care to the uninsured and help rebuild safety...

Vestar reports review of AmBisome progressing toward approval in several countries. (antifungal agent) (Vestar Inc.)
February 18, 1991... Vestar Inc. Vestar Inc. announced that reviews for marketing approval for AmBisome to combat fungal infections is progressing in several additional countries. Dr. Roger J. Crossley, president and chief executive officer, said,...